Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis.
Brown
Sandra M
SM
Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Libbock, TX 79430-7217, USA. sandra.brown@ttuhsc.edu
Khanani
Arshad M
AM
Stetson
Cloyce L
CL
Reid
Ted W
TW
D000063:Accidents, Traffic; D000287:Administration, Topical; D002675:Child, Preschool; D003315:Cornea / Q000294:innervation*; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000009:adverse effects* / Q000627:therapeutic use; D007634:Keratitis / Q000188:drug therapy* / Q000209:etiology; D009883:Ophthalmic Solutions / Q000009:adverse effects / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*; D013373:Substance P / Q000009:adverse effects* / Q000627:therapeutic use; D020433:Trigeminal Nerve Diseases / Q000188:drug therapy* / Q000209:etiology
D009883:Ophthalmic Solutions; D013373:Substance P; D007334:Insulin-Like Growth Factor I